Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Cheng and Emily McDonald.
Matthew Cheng
Connection Strength
0.586
Emily McDonald
  1. Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis. Open Forum Infect Dis. 2019 Jul 01; 6(7).
    View in: PubMed
    Score: 0.208
  2. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis. Int J Infect Dis. 2021 Mar; 104:671-676.
    View in: PubMed
    Score: 0.058
  3. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
    View in: PubMed
    Score: 0.057
  4. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
    View in: PubMed
    Score: 0.056
  5. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
    View in: PubMed
    Score: 0.055
  6. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
    View in: PubMed
    Score: 0.055
  7. MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis. J Infect. 2018 12; 77(6):489-495.
    View in: PubMed
    Score: 0.049
  8. Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia. BMC Infect Dis. 2018 06 11; 18(1):270.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.